Cargando…

PROTHROMBIN COMPLEX CONCENTRATE  IN EMERGENCY DEPARTMENT

Coagulation abnormalities are common in bleeding or critically ill patient and hemostatic management remains a major challenge for the emergency physician. Management of bleeding patients consists of bleeding control, restoration of blood volume, and correction of any associated coagulopathy. Tradit...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nesek Adam, Višnja, Bošan-Kilibarda, Ingrid
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Sestre Milosrdnice University Hospital and Institute of Clinical Medical Research, Vinogradska cesta c. 29 Zagreb 2022
Materias:	Reviews
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9536167/ https://www.ncbi.nlm.nih.gov/pubmed/36304807 http://dx.doi.org/10.20471/acc.2022.61.s1.09

Ejemplares similares

VENOUS THROMBOEMBOLISM IN THE EMERGENCY DEPARTMENT – SINGLE-CENTER EXPERIENCE
por: Jurić, Ivan, et al.
Publicado: (2022)

DIAGNOSIS OF PULMONARY EMBOLISM  IN THE EMERGENCY DEPARTMENT
por: Rošić, Damir, et al.
Publicado: (2022)

Efficacy of prothrombin complex concentrates for the emergency reversal of dabigatran-induced anticoagulation
por: Grottke, Oliver, et al.
Publicado: (2016)

Role of prothrombin complex concentrate in perioperative coagulation therapy
por: Tanaka, Kenichi A, et al.
Publicado: (2014)

Comparison of Analgesic Effect between Gabapentin and Diclofenac on Post-Operative Pain in Patients Undergoing Tonsillectomy
por: Nesek Adam, Visnja
Publicado: (2013)

Clinical review: Prothrombin complex concentrates - evaluation of safety and thrombogenicity
por: Sørensen, Benny, et al.
Publicado: (2011)

The role of prothrombin complex concentrates in reversal of target specific anticoagulants
por: Babilonia, Katrina, et al.
Publicado: (2014)

Use of prothrombin complex concentrate in warfarin anticoagulation reversal in the emergency department: a quality improvement study of administration delays
por: Bordeleau, Simon, et al.
Publicado: (2015)

Prothrombin complex concentrates in warfarin anticoagulation reversal
por: Costa-Lima, Carolina, et al.
Publicado: (2012)

Prothrombin Complex Concentrates Only After Thromboelastography
por: Muggleton, Ellis, et al.
Publicado: (2019)

SEPSIS DEFINITION: WHAT’S NEW  IN THE TREATMENT GUIDELINES
por: Srzić, Ivana, et al.
Publicado: (2022)

VENOMOUS SNAKEBITES IN CROATIA, CLINICAL PRESENTATION, DIAGNOSIS AND TREATMENT
por: Tunjić Pejak, Darinka, et al.
Publicado: (2022)

Thromboembolic Risk of 4-Factor Prothrombin Complex Concentrate versus Fresh Frozen Plasma for Urgent Warfarin Reversal in the Emergency Department
por: Maguire, Michelle, et al.
Publicado: (2019)

Clinical Characteristics and Management of Patients with a Suspected COVID-19 Infection in Emergency Departments: A European Retrospective Multicenter Study
por: Chauvin, Anthony, et al.
Publicado: (2022)

Four-factor prothrombin complex concentrate (Beriplex® P/N) is superior to three-factor prothrombin complex concentrate for reversal of coumarin anticoagulation
por: Herzog, E, et al.
Publicado: (2015)

PERIPHERAL NERVE BLOCKS FOR HIP FRACTURES  IN EMERGENCY MEDICINE
por: Simić, Anđela, et al.
Publicado: (2022)

Emergencies on direct oral anticoagulants: Management, outcomes, and laboratory effects of prothrombin complex concentrate
por: Bavalia, Roisin, et al.
Publicado: (2020)

Role of prothrombin complex concentrate in the severe trauma patient
por: Egea-Guerrero, Juan José, et al.
Publicado: (2022)

Reversal of oral anticoagulation with prothrombin complex concentrate (Octaplex)
por: Riess, H, et al.
Publicado: (2007)

INR reduction after prothrombin complex concentrate (Co-fact(©)) administration: comparison of INR outcomes in different patient categories at the emergency department
por: Roodheuvel, Floris, et al.
Publicado: (2013)

Acquired deficiency of prothrombin complex coagulation factors in major bleeding is a therapeutic indication of 4‐factor prothrombin complex concentrates
por: Wiedermann, Christian J.
Publicado: (2020)

The impact of prothrombin complex concentrates when treating DOAC-associated bleeding: a review
por: Hoffman, Maureane, et al.
Publicado: (2018)

Efficacy and Safety of Prothrombin Complex Concentrates in Liver Transplantation: Evidence from Observational Studies
por: Punzo, Giovanni, et al.
Publicado: (2023)

OUT-OF-HOSPITAL CARDIAC ARREST OUTCOMES – BYSTANDER CARDIOPULMONARY RESUSCITATION RATE IMPROVEMENT
por: Važanić, Damir, et al.
Publicado: (2022)

Using of prothrombin complex concentrate in patients with trauma-induced coagulopathy
por: Tarabrin, O, et al.
Publicado: (2015)

Effectiveness of prothrombin complex concentrate for the treatment of bleeding: A systematic review and meta‐analysis
por: van den Brink, Daan P., et al.
Publicado: (2020)

Prothrombin Complex Concentrates to Treat Coagulation Disturbances: An Overview With a Focus on Use in Infants and Children
por: Munlemvo, Dolly M., et al.
Publicado: (2022)

DRUG-INDUCED HYPERSENSITIVITY SYNDROME CAUSED BY LAMOTRIGINE, A CASE REPORT
por: Vrhovski, Danijela, et al.
Publicado: (2022)

Correction: Clinical review: Prothrombin complex concentrates - evaluation of safety and thrombogenicity
por: Sørensen, Benny, et al.
Publicado: (2011)

Thrombin Generation Capacity of Prothrombin Complex Concentrate in an In Vitro Dilutional Model
por: Grottke, Oliver, et al.
Publicado: (2013)

Theoretical Modeling of Coagulation Management With Therapeutic Plasma or Prothrombin Complex Concentrate
por: Schöchl, Herbert, et al.
Publicado: (2017)

Influence of prothrombin complex concentrates on plasma coagulation in critically ill patients
por: Staudinger, T., et al.
Publicado: (1999)

PROTHROMBIN COMPLEX CONCENTRATE USE IN BELFAST HEALTH AND SOCIAL CARE TRUST
por: Corrigan, C, et al.
Publicado: (2021)

Use and effectiveness of a two‐level initiation strategy for fixed‐dose prothrombin complex concentrate according to the initial international normalized ratio in an emergency department in Japan
por: Suzuki, Kei, et al.
Publicado: (2021)

Management of the Bleeding Patient Receiving New Oral Anticoagulants: A Role for Prothrombin Complex Concentrates
por: Baumann Kreuziger, Lisa M., et al.
Publicado: (2014)

Optimal Dosage and Administration Practices for Vitamin K Antagonist Reversal With 4-Factor Prothrombin Complex Concentrate
por: Rhoney, Denise H., et al.
Publicado: (2020)

Safety of 4-factor prothrombin complex concentrate (4F-PCC) for emergent reversal of factor Xa inhibitors
por: Tao, Jing, et al.
Publicado: (2018)

Clinical utilization of four-factor prothrombin complex concentrate: a retrospective single center study
por: Naeem, Zaina, et al.
Publicado: (2021)

Prothrombin complex concentrate in the management of major bleeding induced by oral anticoagulant therapy
por: AlSheef, Mohammed, et al.
Publicado: (2022)

Anticoagulant effect of prothrombin complex concentrates: a whole blood in vitro study
por: Scharbert, G, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_18lta5248c4i6uvsmdc1lbad6s